FDA Adverse Event Injury Summary report: N

SPACEOAR SYSTEM

MDR report key: 9235476 · Received October 24, 2019

Report

Report Number
3005099803-2019-05140
Event Type
Injury
Date Received
October 24, 2019
Date of Event
September 18, 2019
Report Date
October 24, 2019
Manufacturer
AUGMENIX, INC.
Product Code
OVB
UDI-DI
00864661000102
PMA / PMN Number
K181465
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER. THEREFORE, THE MANUFACTURE DATE AND EXPIRATION DATE ARE UNKNOWN. THE EVENT WAS REPORTED BY THE PATIENT. HOWEVER, PHYSICIANS CONTACT INFORMATION HAS BEEN PROVIDED. INITIAL REPORTER FACILITY NAME: (B)(6) HOSPITAL AND MEDICAL CENTER THE COMPLAINANT INDICATED THAT THE DEVICE HAS BEEN IMPLANTED AND WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION ON SEPTEMBER 27, 2019 THAT SPACEOAR WAS IMPLANTED DURING A SPACEOAR PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2019. REPORTEDLY, THE PATIENT UNDERWENT FOUR FRACTIONS OF RADIATION TREATMENT STARTING (B)(6) 2019. ACCORDING TO THE COMPLAINANT, THE PATIENT EXPERIENCED SIGNIFICANT PAIN IN THE RECTUM AND SURROUNDING AREA A FEW HOURS AFTER THE PROCEDURE AS THE PAIN MEDICATIONS WORE OFF. FIVE DAYS POST PROCEDURE THE PATIENT NOTICED A SIGNIFICANT AMOUNT OF BLOOD DURING EJACULATION. ON (B)(6) 2019, ABOUT THREE TO FOUR DROPS OF BLOOD WAS NOTED AFTER URINATING AND HAVING A BOWEL MOVEMENT. THE PHYSICIAN PRESCRIBED ANTIBIOTICS, TAMSULOSIN HCL 0.4 MILLIGRAMS, AND AZO FOR NINETY DAYS. AS OF (B)(6) 2019, THE PATIENTS SYMPTOMS GRADUALLY IMPROVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1028054 SPACEOAR SYSTEM ABSORBABLE PERIRECTAL SPACER OVB AUGMENIX, INC. SO-2101 00864661000102

Patients

Seq Age Sex Outcome Treatment
1 70 YR Other